The value of confocal microendoscopy probe catheter Np in the diagnosis of pancreatic tumors was explored in a preliminary experiment

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400090210

Enrollment

Unknown

Registered

2024-09-25

Start date

2024-10-08

Completion date

Unknown

Last updated

2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic tumor

Interventions

Gold Standard:Pathological examination results

Index test:confocal microendoscopy probe catheter Np

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80 years who have been diagnosed with pancreatic space occupying lesions by imaging examination (B-ultrasound /CT/MRI); 2. Ultrasound gastroscopy or puncture examination is needed to further confirm the diagnosis; 3. Able to read, understand and sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Severe heart, lung and brain disorders can not tolerate operation 2. Severe mental disorders can not cooperate 3. Acute injury of oropharynx and esophagus has a high risk of endoscopic perforation 4. Patients with severe bleeding tendency 5. Pregnancy or lactation 6. Patients with acute pancreatitis during an attack 7. Patients with allergy to fluorescent agents.

Design outcomes

Primary

Measure	Time frame
Area under curve, AUC;Accuracy;Sensitivity;Specificity;	—

Secondary

Measure	Time frame
Positive predicative value;	—

Countries

China

Contacts

Public Contactding xiangwu

Wuhan Fourth Hospital

xwding@hotmail.com+86 139 7104 2983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026